Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis
about
Ulcerative colitis-associated colorectal cancerNovel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.Cancer surveillance in patients with primary sclerosing cholangitis.Non-polypoid colorectal neoplasms: Classification, therapy and follow-upIncidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasiaEndoscopic submucosal dissection in the colorectum: Feasibility in the Canadian setting.Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.Colorectal cancer in colitis: a relic of the past?Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.Surveillance strategies for colitis-associated cancer: state of the art and future perspectives.What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis.Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel DiseaseClinical significance of indefinite for dysplasia on pouch biopsy in patients with underlying inflammatory bowel disease.Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years' Experience in a Patient Cohort from a Defined Population Area.Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.Colon Cancer: Inflammation-Associated Cancer.A thirty-year follow-up surveillance study for neoplasia of a dutch ulcerative colitis cohort.Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.Colorectal dysplasia and adenocarcinoma in patients with ulcerative colitis: an experience from a tertiary care hospital.
P2860
Q26822499-6869090D-57D6-438A-8E82-D48C4A96CC11Q34088621-7E318818-9DC7-4C81-8C01-0236468F78AAQ35490961-EDC3E433-9D5F-48CC-BF54-358FDDD4DDEFQ35567602-ADB51D78-0487-4DA6-AA18-C73F446F1247Q36212967-EB11A2AE-DCF4-40F3-8818-8ECF79D12FD6Q36294567-B86E85F1-D1E4-4DC3-830A-4D6B45142F38Q37558541-19A0CADC-C4F3-4227-BC22-EBF3E5E53FE1Q38238980-44FD1EBD-7CEE-4FB8-AF2D-73DB054EC1F1Q38273304-2A9C7269-F3C1-46AF-A2DC-83D97DBF0CDCQ38311400-3B901C41-9615-4E13-AE0F-21B2AD7007EEQ38404877-FE49E5BE-91EB-4F3D-A833-2F0A247674A4Q38687411-CDC30E86-C843-40C0-AA26-6C5D17FFCDB9Q38748390-DD3ED7E3-023A-4E35-A14E-50318724C9EAQ38752813-70918149-B0C8-40AB-93CC-12B11E1CDF9EQ42115115-E8930584-1690-4769-89AC-E9F5E91D7C11Q42699714-53971826-06C8-49C3-8044-D79E3688B4A4Q43864339-EC3B7593-DBE4-4A76-84C9-7B31057CF6B7Q50783195-C9FFC810-C1AD-454B-93BB-B9DFA146059BQ51119596-CE4AFA1A-BFAF-4F6C-AFE3-AF95CF7C1C62Q52678768-D6E1D493-72A4-4794-AAD7-D372F6ABC66DQ53244278-DE12E502-2AD9-49AE-B45B-2E91FDE2E3CEQ53251017-DE619249-43FD-4C14-8D03-A95199590523Q53257658-55CBF15D-9E06-40FD-A5DD-D0289EB39FADQ55387241-385C1B80-7000-4E2F-9037-31546F7AA682
P2860
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcome after surveillance of ...... tients with ulcerative colitis
@en
Outcome after surveillance of ...... ients with ulcerative colitis.
@nl
type
label
Outcome after surveillance of ...... tients with ulcerative colitis
@en
Outcome after surveillance of ...... ients with ulcerative colitis.
@nl
prefLabel
Outcome after surveillance of ...... tients with ulcerative colitis
@en
Outcome after surveillance of ...... ients with ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Outcome after surveillance of ...... tients with ulcerative colitis
@en
P2093
Amy Noffsinger
David T Rubin
Dezheng Huo
Jami A Rothe
Jeremy T Hetzel
Jerrold R Turner
Joel R Pekow
Stephen B Hanauer
P2860
P304
P356
10.1002/IBD.21184
P577
2010-08-01T00:00:00Z